MedTrace Logo

Brief Exposure and Exercise for PTSD.

NCT07080606 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2026-04-08

No results posted yet for this study

Summary

The goal of this clinical trial is to learn if 8 sessions of brief exposure and exercise therapy works to treat Post Traumatic Stress Disorder (PTSD) in adults. This study will also learn if participants think brief exposure and exercise therapy is a good and doable treatment. and The main questions it aims to answer are:

* Do participants find brief exposure and exercise an acceptable and feasible means of treatment for PTSD?
* Does brief exposure and exercise decreases of the severity of PTSD symptoms?

Participants will:

* Complete weekly questionnaires for 10-14 weeks.
* Attend 8 twice weekly exposure therapy and exercise sessions for 4 weeks.

Conditions

  • PTSD - Post Traumatic Stress Disorder

Interventions

BEHAVIORAL

Brief exposure therapy and exercise

Treatment provided in this study includes an open label brief imaginal exposure therapy for Post Traumatic Stress Disorder (PTSD) and moderate intensity aerobic exercise (i.e., 70-75% max heart rate). Participants all receive 30 minutes of psychotherapy and 25 minutes of exercise.

Sponsors & Collaborators

  • Troy Hubert

    lead OTHER

Principal Investigators

  • Jessica Burris, Ph.D. · University of Kentucky

  • Shannon Sauer-Zavala, Ph.D. · University of Kentucky

  • Troy J.J. Hubert, M.S. · University of Kentucky

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-06-25
Primary Completion
2026-03-02
Completion
2026-03-02

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07080606 on ClinicalTrials.gov